Palvella Therapeutics (PVLA) Curent Deferred Tax Liability (2013 - 2015)

Palvella Therapeutics (PVLA) has reported Curent Deferred Tax Liability for 3 consecutive years, with $24464.0 the latest figure, recorded in Q3 2015.

• In Q3 2015, Curent Deferred Tax Liability changed N/A year-over-year to $24464.0; the TTM figure through Sep 2015 stood at $24464.0 (changed N/A YoY), while the FY2014 annual figure was $26522.0, up 40.5% from the prior year.
• Curent Deferred Tax Liability held at $24464.0 in Q3 2015 per PVLA's latest filing, from $24446.0 in the prior quarter.
• Across five years, Curent Deferred Tax Liability topped out at $26522.0 in Q4 2014 and bottomed at $18877.0 in Q4 2013.
• Historically, Curent Deferred Tax Liability has averaged $23570.0 across 3 years, with a median of $24446.0 in 2015.
• On a YoY basis, Curent Deferred Tax Liability climbed as much as 40.5% in 2014 and fell as far as 40.5% in 2014.
• Palvella Therapeutics' Curent Deferred Tax Liability stood at $18877.0 in 2013, then jumped by 40.5% to $26522.0 in 2014, then decreased by 7.76% to $24464.0 in 2015.
• Business Quant data shows PVLA's Curent Deferred Tax Liability at $24464.0 in Q3 2015, $24446.0 in Q2 2015, and $23541.0 in Q1 2015.